The combined anti-TB drugs.
Treatment and prevention of all forms and localisations of tuberculosis.
Increased hypersensitivity to any component of the drug.
Epilepsy and other diseases, which are accompanied by a tendency to seizures, severe psychosis, polio (including history), toxic hepatitis in anamnesis due to the use of derivatives of isonicotinic acid hydrazide (ftivazid etc), Expressed atherosclerosis, acute liver and / or renal failure; renal failure (nephritis), liver (hepatitis, cirrhosis), liver disease in the acute stage; amyloidosis, peptic ulcer disease, myxedema, cardiac decompensation, hypothyroidism.
Granules as microspheres of regular and irregular form, pink.
Keep in a dark place at a temperature not exceeding 25 °C. Keep out of the reach of children.